Similar articles

• [Pharmacologic agents for preventing and treating motion sickness].

  Shashkov VS, Sabaev VV. Shashkov VS, et al. Kosm Biol Aviakosm Med. 1981 Jan-Feb;15(1):9-18. Kosm Biol Aviakosm Med. 1981. PMID: 6111621 Review. Russian. No abstract available.
• Antimotion sickness drug efficacy.

  Wood CD, Cramer DB, Graybiel A. Wood CD, et al. Otolaryngol Head Neck Surg. 1981 Nov-Dec;89(6):1041-4. doi: 10.1177/019459988108900632. Otolaryngol Head Neck Surg. 1981. PMID: 6121316 No abstract available.
• [Therapeutic considerations on kinetoses].

  Ferrotti A. Ferrotti A. Minerva Med. 1970 Apr 7;61(28):1408-16. Minerva Med. 1970. PMID: 4396663 Italian. No abstract available.
• [Problems in the drug prevention of the seasickness syndrome (motion sickness)].

  Shashkov VS, Sabaev VV, Il'ina SL, Galle RR. Shashkov VS, et al. Farmakol Toksikol. 1987 May-Jun;50(3):5-20. Farmakol Toksikol. 1987. PMID: 2886362 Review. Russian. No abstract available.
• Psychophysiological aspects of motion sickness.

  Murray JB. Murray JB. Percept Mot Skills. 1997 Dec;85(3 Pt 2):1163-7. doi: 10.2466/pms.1997.85.3f.1163. Percept Mot Skills. 1997. PMID: 9450266 Review.